Prolonged increased concentrations of 17beta-estradiol associated with development of persistent ovarian follicles do not influence conception rates in beef cattle.
Objectives were to evaluate conception rates and time to estrus following cessation of treatments designed to either cause prolonged elevated concentrations of 17beta-estradiol associated with development of persistent ovarian follicles or to inhibit elevated concentrations of 17beta-estradiol and development of persistent ovarian follicles. Beef heifers (n = 80) and 2-yr-old nonlactating cows (n = 39) were stratified by age, blocked by estrual status (previously exhibited estrus or anestrus) and assigned to receive either 1) four norgestomet implants (4 Norg; n = 59) for 9 d (d 0 = treatment initiation) or 2) one norgestomet implant from d 0 to 7 and three additional norgestomet implants from d 7 to 9 (1 + 3 Norg; n = 60). All animals received PGF2alpha on d 0 to lyse corpora lutea. All implants were removed on d 9 followed by estrus detection every 6 h for 7 d following implant removal. Females exhibiting estrus were artificially inseminated 6 to 12 h after detection of estrus. A treatment x day interaction (P < .01) for concentrations of 17beta-estradiol from d 0 to 9 of the experiment with elevated 17beta-estradiol occurring in females treated with 1 + 3 Norg implants. The interval from treatment withdrawal to estrus was longer (P < .01) in females treated with 1 + 3 Norg (105 h) than in those treated with 4 Norg (61 h). Synchrony of estrus among anestrous females was greater (P < .10) in females treated with 4 Norg (97%) than in females treated with 1 + 3 Norg (67%) but was similar in estrual females. Conception rates (number conceiving to AI/number bred by AI) did not differ (4 Norg = 67%; 1 + 3 Norg = 72%; P > .10). Pregnancy rates (number conceiving to AI/number in treatment group) also did not differ between treatment groups of either estrual or anestrous females. Conception rates are not compromised in females that develop persistent ovarian follicles and have prolonged elevated concentrations of 17beta-estradiol when persistent ovarian follicles are not allowed to ovulate.
Fike
K E
KE
Department of Animal Science, University of Nebraska, Lincoln 68583-0908, USA.
Wehrman
M E
ME
Bergfeld
E G
EG
Kojima
F N
FN
Kinder
J E
JE
D000818:Animals; D002417:Cattle / Q000502:physiology*; D015237:Dinoprost / Q000008:administration & dosage / Q000494:pharmacology; D004343:Drug Implants; D004958:Estradiol / Q000097:blood* / Q000502:physiology*; D004971:Estrus / Q000502:physiology; D004973:Estrus Synchronization / Q000187:drug effects / Q000502:physiology; D005260:Female; D006080:Ovarian Follicle / Q000502:physiology*; D011247:Pregnancy; D018873:Pregnancy Rate; D011282:Pregnenediones / Q000008:administration & dosage / Q000494:pharmacology; D045167:Progesterone Congeners / Q000008:administration & dosage / Q000494:pharmacology; D011863:Radioimmunoassay / Q000379:methods / Q000662:veterinary; D013997:Time Factors
D004343:Drug Implants; D011282:Pregnenediones; D045167:Progesterone Congeners; C100284:norgestomet; D004958:Estradiol; D015237:Dinoprost